Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Should uncertainty concerning the risk of malignancy be included in diagnostic (nongynecologic) cytopathology reports?
Publication

Publications

Should uncertainty concerning the risk of malignancy be included in diagnostic (nongynecologic) cytopathology reports?

Title
Should uncertainty concerning the risk of malignancy be included in diagnostic (nongynecologic) cytopathology reports?
Type
Article in International Scientific Journal
Year
2020
Authors
Poller, DN
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Fernando Schmitt
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: Cancer CytopathologyImported from Authenticus Search for Journal Publications
ISSN: 1934-662X
Publisher: Wiley-Blackwell
Other information
Authenticus ID: P-00S-F3C
Abstract (EN): In diagnostic cytology, the known site-specific false positive rates at various anatomical sites for the risk malignancy (ROM) when a confirmed malignant diagnosis is made are comparatively well documented. ROM figures for diagnostic cytology specimens may vary according to the anatomical site of the specimen, the exact nature of the specimen received, the staining method(s) used, and the use of additional laboratory techniques including molecular profiling; furthermore, they often differ to some extent from institution to institution, between differing cytologists within the same institution, and over time. A brief literature review for a selected group of routine diagnostic cytology specimens shows a published ROM for a confirmed malignant diagnosis as follows: bile duct brushings, similar to 99% (range, 97%-100%); breast fine needle aspiration, 98.5% (range, 92%-100%); serous effusion fluid, 98.9% (range, 90%-100% although lower for squamous cell carcinoma, mesothelioma, and lymphoma), pulmonary endobronchial ultrasound cytology, similar to 99% (range, 86.6%-100%); thyroid FNA, 98% (range, 97%-99% if NIFTP tumors are excluded), salivary gland FNA, similar to 90%; (range 57%-100%) and lateral neck cyst FNA, similar to 99% (range, 95.5%-100%). Because most diagnostic cytology specimens have a small but accepted false-positive rate, this information is vitally important for the clinical management of patients and for shared patient decision making. In our view, the known false-positive rate for a given diagnostic cytology specimen could be included within the cytology report to assist in explaining the limitations of the diagnostic cytology interpretation and help facilitate the clinical decision-making process.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Thyroid FNAC: Causes of false-positive results (2018)
Article in International Scientific Journal
Malheiros, DC; Canberk, S; Poller, DN; Fernando Schmitt

Of the same journal

Thyroid FNA: International Perspectives From the European Congress of Cytopathology-Can We Cross the Bridge of Classifications? (2015)
Another Publication in an International Scientific Journal
Rossi, ED; Pusztaszeri, M; Fernando Schmitt; Bongiovanni, M; Chandra, A; Faquin, WC
Role of ancillary studies in fine-needle aspiration from selected tumors (2012)
Another Publication in an International Scientific Journal
Fernando Schmitt; Barroca, H
MicroRNA signatures in cytopathology: Are they ready for prime time? (2016)
Another Publication in an International Scientific Journal
Beca, F; Fernando Schmitt
Growing Indication for FNA to Study and Analyze Tumor Heterogeneity at Metastatic Sites (2014)
Another Publication in an International Scientific Journal
Beca, F; Fernando Schmitt

See all (15)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-01 at 10:02:46 | Privacy Policy | Personal Data Protection Policy | Whistleblowing